Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 626 results for "fda centre for drug evaluation and re..."

ReNeuron Group has filed an Investigational New Drug (IND) app...

ReNeuron Group has filed an Investigational New Drug (IND) application with the US FDA to commence a Phase I/II clinical trial with its human Retinal Progenitor Cell (hRPC)therapy candidate for retinitis pigmentosa (RP). RP is a group of ... Money Week, 6 days ago
ReNeuron seeks to begin Phase 1/11 trials for hRPC Stock Market Wire, 6 days ago
ReNeuron seeks to begin Phase 1/11... This is Money, 6 days ago

9 images for fda centre for drug evaluation and research

OncLive, 1 month ago
OncLive, 2 months ago
OncLive, 3 months ago
Nature Reviews Drug Discovery, 2 months ago
U.S. Food and Drug Administration, 5 months ago
Grist Magazine, 6 months ago
Genetic Engineering News, 6 months ago
Grist Magazine, 6 months ago
Grist Magazine, 6 months ago
Medical Plastics News

Phillips-Medisize adds a human touch

During the development phases, pharma or medical device companies can encounter obstacles complying with the FDA's drug and medical device regulations, as well as other global regulations that determine which current good manufacturing practices ...
 Medical Plastics News4 days ago
European Pharmaceutical Review

Clovis Oncology receives Breakthrough Therapy designation for rucaparib for treatment of advanced ovarian cancer in patients with BRCA-mutated tumours

Clovis Oncology has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the Company's investigational agent rucaparib as monotherapy treatment of advanced ovarian cancer in patients who have ...
 European Pharmaceutical Review1 week ago

FDA approves new antifungal drug Cresemba

Trends in Employment: What Age Groups Get the Jobs? by : Friday 01:16:07 CT Categories: economy, markets, stream One interesting fact in today's jobs report (see Diving Into the Payroll Report: Establishment +295K Jobs; Household +96K ...
 Mr Top Step1 month ago

EGI gets FDA clearance for trials on GTEN

Electrical Geodesics has received clearance from the US Food and Drug Administration of an investigational device exemption (IDE) which will allow the company to undertake clinical studies seeking to demonstrate the safety and feasibility of its ...
 MoneyAM1 month ago

Cerulean inks pact with GOG Foundation to conduct phase 1b trial of CRLX101 in combo with weekly paclitaxel in relapsed ovarian cancer

Cerulean Pharma, a leader in dynamic tumour targeting, has signed a clinical research agreement with the GOG Foundation Inc. to conduct an open-label phase 1b clinical trial of its lead product candidate, CRLX101, in combination with weekly ...
 PharmaBiz1 month ago
Castanet.net

Concerns raised about anesthetics for kids

TORONTO Does anesthesia damage the developing brains of young children? Some experts, including from the U.S. Food and Drug Administration, say this is a pressing question that needs to be answered. A group from the FDA, Northwestern University, ...
 Metro Canada1 month ago Experts call for research into safety of anesthetic use in small children  610 CKTB1 month ago Anesthesia OK for kids?  Castanet.net1 month ago

Advaxis Announces First Patient Treated in Phase 1/2 Dose-Escalation Study of ADXS-HPV for Recurrent Cervical Cancer

The interventional, open-label, non-randomized dose-escalation study is designed to evaluate the safety, efficacy and immunological effect of ADXS-HPV administered at doses up to 1 x10 10 colony forming units (CFU) in repeat cycles of treatment in ...
 Morningstar.com1 month ago Advaxis, Inc. Announces First Patient Treated In Phase 1/2 Dose-Escalation Study Of ADXS-HPV For Recurrent Cervical Cancer  BioSpace1 month ago
[x]  

Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'

(GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/3fs8dg/the_generic_drugs ) has announced the addition of SNS Research's new report "The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & ...
 RCL Advisors1 month ago The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts  Pharmacy Choice1 month ago The Generic Drugs Market: 2015 2030 - Opportunities, Challenges, Strategies & Forecasts  Research and Markets1 month ago
[x]  

Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions

/PRNewswire/ -- RnRMarketResearch.com adds "Global and Chinese Blood Glucose Meters Industry, 2009-2019 Market Research Report" and "The Global Self-Monitoring of Blood Glucose Market to 2025" reports with 2019 and 2025 forecasts data and ...
 Ulitzer1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less